Ponvory

Here's a Multibillion-Dollar Market for Johnson & Johnson
Motley Fool
Tue, 04/13/21 - 10:26 am
JNJ
Ponvory
MS
multiple sclerosis
FDA approves Janssen’s PONVORY for treatment of multiple sclerosis
Pharmaceutical Business Review
Mon, 03/22/21 - 10:35 am
JNJ
Janssen
FDA
Ponvory
relapsing multiple sclerosis
MS
J&J nabs FDA nod for Ponvory, joining Novartis, Bristol Myers in crowded MS market
Fierce Pharma
Fri, 03/19/21 - 10:56 am
JNJ
Ponvory
Novartis
Bristol-Myers Squibb
MS
multiple sclerosis